Support versus inhibition of hematopoiesis by two characterized stromal cell types

Stem Cells
E SitnickaN S Wolf

Abstract

Stromal cells are believed to regulate hematopoiesis through direct cell-cell contact interactions and the release of growth factors. Many questions remain, however, about their lineage derivation and functional heterogeneity. We have previously shown that the adherent nontransformed, nonimmortalized murine bone marrow stromal cell population consists of three cell types which could be grown separately in vitro. Based on the phenotype characterization and expression of surface antigens, we proposed a classification listing for murine bone marrow stromal cells as macrophages, endothelial-like cells and myofibroblasts that display smooth muscle-like characteristics in culture. The present study describes the ability of each of these freshly isolated separated murine stromal cell populations to support the growth of primitive hematopoietic stem cells previously characterized as highly enriched in long-term repopulating cells (LTRC). Of the three stromal cell types tested only the myofibroblasts were capable of support for multilineage hematopoiesis derived in vitro from LTRC in a cloning ring culture system. Endothelial-like cells had an inhibitory effect on the proliferation of LTRC and their descendant cells that was induced by ...Continue Reading

References

Jun 1, 1977·Journal of Cellular Physiology·T M DexterL G Lajtha
Oct 7, 1976·Differentiation; Research in Biological Diversity·T D Allen, T M Dexter
Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·C C FraserR K Humphries
Jul 1, 1992·Baillière's Clinical Haematology·B R ClarkT M Dexter
Aug 1, 1992·Journal of Cellular Physiology·P S TungI B Fritz
Jan 1, 1991·Critical Reviews in Oncology/hematology·J S Greenberger
Jan 1, 1991·Tissue & Cell·M RosendaalC R Green
Mar 1, 1991·The Journal of Experimental Medicine·K MiyakeP W Kincade
Mar 1, 1991·European Journal of Haematology·J NemunaitisJ W Singer
Jan 1, 1990·Annual Review of Immunology·K Dorshkind
Jul 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·S Aizawa, M Tavassoli
May 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·K Harigaya, H Handa
Jul 5, 1968·Science·M Tavassoli, W H Crosby
May 1, 1982·Scandinavian Journal of Haematology·S A Bentley, T S Tralka
Jan 1, 1981·Cell and Tissue Research·A M Duijvestijn, E C Hoefsmit
Apr 1, 1995·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·S P HauserD A Lipschitz

❮ Previous
Next ❯

Citations

Jul 27, 2000·Journal of Cellular Physiology·M YamadaK Motoyoshi
Jan 21, 2000·Experimental Hematology·J P Remy-MartinP Charbord
Jul 21, 1999·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·N B Nardi, Z Z Alfonso
May 29, 2002·Gene Therapy·A J WagersI L Weissman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.